Thursday, 02 April 2020

China News

  • China's JHL Biotech raises $35 million

    China |  News | By BioSpectrum Bureau  | 0 Comment | 23 Jun, 2014

    Singapore: China based emerging biopharmaceutical company, JHL Biotech, has closed a Series B financing round of $35 million, funded by Milestone Capital and a consortium of Taiwan venture ...Read more

  • RAPS, SFDA to collaborate on regulatory training

    China |  News | By BioSpectrum Bureau  | 0 Comment | 12 Nov, 2012

    Singapore: The Regulatory Affairs Professionals Society (RAPS) and China's State Food and Drug Administration Institute of Executive Development (SFDAIED) have signed a memorandum of under...Read more

  • China's largest cord blood bank gets AABB nod

    China |  News | By BioSpectrum Bureau  | 0 Comment | 03 Apr, 2013

    Singapore: China Cord Blood, the largest cord blood banking operator in China, announced that its Beijing subsidiary has been granted the AABB accreditation, for its excellence in providin...Read more

  • Telemedicine is revolutionizing healthcare access

    China |  Analysis | By BioSpectrum Bureau  | 1 Comment | 30 Nov, 2012

    Telemedicine is re-defining access to healthcare in many ways. It has, in particular, proved to be an effective solution in providing specialty healthcare, improving access and reducing cos...Read more

  • China drugstores gets NASDAQ delisting notice

    China |  News | By BioSpectrum Bureau  | 0 Comment | 13 May, 2013

    Singapore: China Jo-Jo Drugstores, a retail and wholesale distributor of pharmaceutical and other healthcare products in China, has been notified by the NASDAQ Stock Market that the firm ha...Read more

  • Transgene, Tasly joint venture begins operations

    China |  News | By BioSpectrum Bureau  | 0 Comment | 27 Jul, 2012

    Singapore: Transgene's Chinese 50:50 equity joint venture with Tasly Pharmaceutical has started its operations. The joint venture will initially develop four Transgene products: TG3003, a m...Read more

  • China Cord Blood files annual report on Form 20-F

    China |  News | By BioSpectrum Bureau  | 0 Comment | 01 Aug, 2012

    Singapore: China Cord Blood Corporation (CCBC), China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing, and stem cell storage services, fi...Read more

  • China Health Resource reports 234% growth

    China |  Company results | By BioSpectrum Bureau  | 0 Comment | 29 May, 2012

    Singapore: China Health Resource revealed results of earnings for the year ending December 31, 2011, and for the first quarter (Q1) of 2012. Revenues for the year ending December 31, 2011, ...Read more

  • Taiwan, China firms to co-develop cancer NCEs

    China |  News | By BioSpectrum Bureau  | 0 Comment | 03 Jan, 2013

    Singapore: Taiwan's PharmaEngine has collaborated and signed research agreement with China's Guangzhou BeBetter Medicine Technology. The two companies will collaborate to design, synthesize...Read more

  • Hunan Hansen buys 80% Chinese med firm for $44m

    China |  News | By BioSpectrum Bureau  | 0 Comment | 08 Nov, 2013

    Singapore: Hunan Hansen Pharmaceutical is looking to buy Yunnan Yongzitang Pharmaceutical. Hunan Hansen is expected to pay $44.8 million (282 million RMB) in an attempt to purchase an 80 p...Read more

  • BMS commits to fight diabetes in China, India

    China |  Influencers | By BioSpectrum Bureau  | 0 Comment | 13 Jun, 2012

    Together on Diabetes, a Bristol-Myers Squibb initiative, is the largest corporate philanthropic commitment to fight type 2 diabetes. Working with well-respected community-based regional and...Read more

  • China cancels Gilead hepatitis, HIV/AIDS patent

    China |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 31 Jul, 2013

    Singapore: A patent for hepatitis B and HIV/AIDS drug Viread has been invalidated by China's State Intellectual Property Office (SIPO). The drug is being manufactured by Gilead Sciences. T...Read more

  • Consumers are winners in the BRCA gene case

    China |  News | By BioSpectrum Bureau  | 0 Comment | 09 Jul, 2013

    In the wake of US Supreme Court's win-win verdict in Association for Molecular Pathology vs Myriad Genetics case, Frost and Sullivan life sciences industry analysts, Mr Justin Collishaw and...Read more

  • Stem cell scientist sues Nobel Prize assembly

    China |  News | By BioSpectrum Bureau  | 0 Comment | 07 Dec, 2012

    Singapore: Dr Rongxiang Xu, the founder of 'human body regenerative restoration science' and a renowned medical scientist, filed a lawsuit against the Nobel Assembly at Karolinska Institut...Read more

  • Chugai Pharma enters China Medical City

    China |  News | By BioSpectrum Bureau  | 0 Comment | 31 Dec, 2013

    Singapore: Chugai Pharmaceutical has announced that it has signed an agreement with the Taizhou Medical High-Tech Industrial Development Zone, a special economic zone in Taizhou, Jiangsu Pr...Read more

  • Promega opens new facility in Shanghai

    China |  News | By BioSpectrum Bureau  | 0 Comment | 19 Nov, 2012

    Singapore: Promega opened a new facility in Shanghai for its China operations. The new site for Shanghai Promega Biological Products replaces an existing molecular biology reagent productio...Read more

  • Tianyin Pharma Qionglai facility will be ready by April

    China |  News | By BioSpectrum Bureau  | 0 Comment | 08 Apr, 2013

    Singapore: Tianyin Pharmaceutical revealed that the progress made in the construction of its Qionglai facility (QLF) is in accordance with its schedule. After meeting several progress mile...Read more

  • Lilly expands partnership with Novast

    China |  News | By BioSpectrum Bureau  | 0 Comment | 13 Jun, 2012

    Singapore: In support of its commitment to maximize growth opportunities in China, Eli Lilly has decided to increase its network of manufacturing capabilities in this key emerging market co...Read more